Laurus Labs Balance Sheet Health
Financial Health criteria checks 2/6
Laurus Labs has a total shareholder equity of ₹41.4B and total debt of ₹27.2B, which brings its debt-to-equity ratio to 65.7%. Its total assets and total liabilities are ₹87.3B and ₹45.9B respectively. Laurus Labs's EBIT is ₹3.6B making its interest coverage ratio 1.9. It has cash and short-term investments of ₹449.2M.
Key information
65.7%
Debt to equity ratio
₹27.22b
Debt
Interest coverage ratio | 1.9x |
Cash | ₹449.20m |
Equity | ₹41.44b |
Total liabilities | ₹45.85b |
Total assets | ₹87.29b |
Recent financial health updates
Laurus Labs (NSE:LAURUSLABS) Takes On Some Risk With Its Use Of Debt
Oct 26Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?
Dec 01These 4 Measures Indicate That Laurus Labs (NSE:LAURUSLABS) Is Using Debt Reasonably Well
Jul 06Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?
Dec 18Is Laurus Labs (NSE:LAURUSLABS) Using Too Much Debt?
Sep 09Laurus Labs (NSE:LAURUSLABS) Has A Somewhat Strained Balance Sheet
Jun 11Recent updates
Laurus Labs (NSE:LAURUSLABS) Is Due To Pay A Dividend Of ₹0.40
Oct 28Laurus Labs (NSE:LAURUSLABS) Takes On Some Risk With Its Use Of Debt
Oct 26Here's Why It's Unlikely That Laurus Labs Limited's (NSE:LAURUSLABS) CEO Will See A Pay Rise This Year
Jul 05Laurus Labs Limited's (NSE:LAURUSLABS) Price In Tune With Revenues
Jul 03Laurus Labs' (NSE:LAURUSLABS) Dividend Will Be ₹0.40
Apr 28Laurus Labs Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Jan 27Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?
Dec 01Laurus Labs (NSE:LAURUSLABS) Is Paying Out Less In Dividends Than Last Year
Oct 22These 4 Measures Indicate That Laurus Labs (NSE:LAURUSLABS) Is Using Debt Reasonably Well
Jul 06Laurus Labs (NSE:LAURUSLABS) Is Paying Out A Dividend Of ₹1.20
Apr 30Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?
Dec 18Is Laurus Labs Limited (NSE:LAURUSLABS) Expensive For A Reason? A Look At Its Intrinsic Value
Sep 27Is Laurus Labs (NSE:LAURUSLABS) Using Too Much Debt?
Sep 09Laurus Labs (NSE:LAURUSLABS) Has A Somewhat Strained Balance Sheet
Jun 11Laurus Labs (NSE:LAURUSLABS) Is Paying Out A Larger Dividend Than Last Year
May 02Laurus Labs (NSE:LAURUSLABS) Seems To Use Debt Quite Sensibly
Feb 26With EPS Growth And More, Laurus Labs (NSE:LAURUSLABS) Is Interesting
Feb 11Does Laurus Labs (NSE:LAURUSLABS) Have A Healthy Balance Sheet?
Nov 26Laurus Labs (NSE:LAURUSLABS) Is Due To Pay A Dividend Of ₹0.80
Nov 13I Ran A Stock Scan For Earnings Growth And Laurus Labs (NSE:LAURUSLABS) Passed With Ease
Nov 12Laurus Labs (NSE:LAURUSLABS) Has Affirmed Its Dividend Of ₹0.80
Oct 30A Look At The Intrinsic Value Of Laurus Labs Limited (NSE:LAURUSLABS)
Oct 05Should You Be Adding Laurus Labs (NSE:LAURUSLABS) To Your Watchlist Today?
Aug 10Laurus Labs (NSE:LAURUSLABS) Seems To Use Debt Quite Sensibly
Jul 23Is Laurus Labs Limited (NSE:LAURUSLABS) Worth ₹547 Based On Its Intrinsic Value?
Jun 06Financial Position Analysis
Short Term Liabilities: LAURUSLABS's short term assets (₹41.2B) exceed its short term liabilities (₹34.6B).
Long Term Liabilities: LAURUSLABS's short term assets (₹41.2B) exceed its long term liabilities (₹11.3B).
Debt to Equity History and Analysis
Debt Level: LAURUSLABS's net debt to equity ratio (64.6%) is considered high.
Reducing Debt: LAURUSLABS's debt to equity ratio has increased from 59.5% to 65.7% over the past 5 years.
Debt Coverage: LAURUSLABS's debt is not well covered by operating cash flow (9.1%).
Interest Coverage: LAURUSLABS's interest payments on its debt are not well covered by EBIT (1.9x coverage).